Pre-natal blood test study leads to 'unexpected' cancer diagnosis in three women

June 5, 2015, Cancer Research UK
Pre-natal blood test study leads to ‘unexpected’ cancer diagnosis in three women

Researchers in Belgium trying to improve a blood test used to spot foetal disorders have found unexpected signs of cancer in three of the 4000 pregnant women on their study.

UK experts said the findings were 'important', but stressed that there was a long way to go before the work could be harnessed to routinely improve cancer diagnosis or treatment.

Non-invasive pre-natal testing, or NIPT, is used to test for conditions such as Down's syndrome before birth. It works by looking for certain changes in a foetus's DNA that can be isolated from the mother's blood.

It is not generally used on the NHS but is available privately.

Dr Nathalie Brison, from the Centre for Human Genetics in Leuven, Belgium, said her team initially set out to improve the accuracy of the test.

"Even though [NIPT] is very reliable, we believed that we could make it even better," she said.

A key challenge was to try to test for a wider range of genetic abnormalities.

Using their experimental test in more than 4000 women, the team identified abnormalities in three of them that could not be linked to either the mother or her foetus.

Further analysis revealed DNA changes that "bore a resemblance to those found in cancer, and [we] referred the women to the oncology unit," said Brison.

After whole body MRI scanning and subsequent tissue analysis, the three women were diagnosed with ovarian cancer, a follicular lymphoma, and a Hodgkin lymphoma.

Two out of the three women were treated, one of them during pregnancy. She subsequently gave birth to a healthy girl.

Follow-up investigations in the treated women showed that their DNA profiles became normal again during and after chemotherapy. This, the researchers say, suggests that the technique had the added advantage of monitoring how effective the treatment is.

The third woman had an 'indolent' (slow growing) lymphoma that did not immediately need treatment.

Professor Jacqui Shaw, a Cancer Research UK expert in tumour DNA analysis, said: "These important findings highlight the growing evidence that a cancer's abnormal DNA may be present in a person's blood, and that this could be used to help diagnose, track and the disease. This includes detecting an undiagnosed cancer during pregnancy, allowing for treatment during pregnancy.

"But larger studies will be needed to confirm these 'proof of concept' findings, and ensure this type of analysis is accurate before it could be tested in clinical trials."

The findings have already led to further research, including a study monitoring the blood of people with Hodgkin lymphoma after treatment.

The study was published in the journal JAMA Oncology.

Explore further: Invasive procedures down with noninvasive prenatal testing

More information: "Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing" JAMA Oncol. Published online June 05, 2015. doi:10.1001/jamaoncol.2015.1883

"Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study." DOI: dx.doi.org/10.1016/S2352-3026(14)00039-8

Related Stories

Invasive procedures down with noninvasive prenatal testing

December 18, 2014
(HealthDay)—The number of invasive diagnostic procedures, including amniocentesis, is down significantly after the introduction of noninvasive prenatal testing (NIPT), according to a study published in the January issue ...

Study finds NIPT detects more than 80 percent of chromosomal abnormalities

February 3, 2014
In a study to be presented on Feb. 6 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal ...

ASHG and ESHG issue position statement on non-invasive prenatal screening

March 25, 2015
Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to test blood drawn from ...

Study confirms accuracy of its NIFTY in nearly 147,000 pregnancies

February 5, 2015
BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed ...

Abnormalities in pregnancies with failures for noninvasive prenatal testing

February 2, 2015
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate ...

Changes to prenatal screening for Down syndrome suggested

December 5, 2013
Western Australian researchers say the inclusion of non-invasive prenatal testing (NIPT) into the current Down syndrome screening program would increase detection rates, reduce invasive diagnostic testing and as a result ...

Recommended for you

Air pollutants linked to abnormal fetal growth

February 23, 2018
Chinese mothers who were exposed to a high level of certain air pollutants during pregnancy had a higher risk of abnormal fetal growth, according to a new Yale School of Public Health (YSPH) study.

Scientists discover critical molecular biomarkers of preeclampsia

February 21, 2018
Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death. It is also a leading cause of maternal ...

Transgender women can breastfeed, first case study shows

February 16, 2018
The first scientific case study has been published describing how a US transgender woman was able to breastfeed her adopted infant by taking hormones that induce lactation.

Controversial pregnancy test drug shows deformities in zebrafish embryos within hours of exposure

February 13, 2018
The components of a controversial drug, allegedly linked to birth defects in the 1960s and '70s, caused deformations to fish embryos just hours after they received a dose in new studies by researchers at the University of ...

Direct link between glands and implanting embryos critical to pregnancy

February 9, 2018
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy—offering clues to unsolved questions in pregnancy.

Lab-grown eggs could pave way towards new fertility treatments

February 8, 2018
Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.